Gujarat Themis Biosyn board to consider fund raising on Jun 19

1 min read     Updated on 16 Jun 2026, 10:15 PM
scanx
Reviewed by
Naman SScanX News Team
AI Summary

Gujarat Themis Biosyn Limited's board will meet on June 19, 2026, to consider raising funds through equity shares and debentures. The proposal includes preferential issues and private placements, subject to regulatory and shareholder approvals.

powered bylight_fuzz_icon
43173905

*this image is generated using AI for illustrative purposes only.

Gujarat Themis Biosyn Limited has scheduled a meeting of its Board of Directors on June 19, 2026, to evaluate a proposal for raising funds. The board will consider issuing equity shares or various securities, including Compulsory Convertible Debentures, Optionally Convertible Debentures, and Non-Convertible Debentures. The proposed fund raising may be conducted through a preferential issue on a private placement basis or any other permissible manner.

The company intends to undertake this issuance in accordance with the provisions of the SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018, and the Companies Act, 2013. The execution of the proposal remains subject to necessary approvals, including those from the shareholders of the company and the relevant stock exchanges.

Key Agenda Items

The Board meeting will focus on the following primary objective:

  • Evaluation of fund raising: Assessing the proposal to raise capital through equity shares or debt instruments.

Proposed Instruments

The company has identified specific financial instruments for potential issuance:

Instrument Type Description
Equity Shares Shares to be issued potentially via preferential allotment.
Compulsory Convertible Debentures Debt instruments that mandatorily convert into equity.
Optionally Convertible Debentures Debt instruments with an option to convert into equity.
Non-Convertible Debentures Pure debt instruments without an equity conversion option.

The intimation regarding the board meeting was submitted to the BSE Limited and the National Stock Exchange of India Limited under Regulation 29(1)(d) of the SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015.

Historical Stock Returns for Gujarat Themis Biosyn

1 Day5 Days1 Month6 Months1 Year5 Years
-1.69%-5.81%+2.24%-3.06%+9.26%+55.51%

What specific capital requirements or expansion plans is Gujarat Themis Biosyn aiming to support with this fund raise?

How will the potential dilution of equity impact existing shareholders if the company opts for convertible instruments?

What is the company's current debt-to-equity ratio, and how might issuing Non-Convertible Debentures affect its leverage?

like17
dislike

Gujarat Themis Biosyn seeks approval to raise ₹1,000 crore via QIP

1 min read     Updated on 10 Jun 2026, 04:06 AM
scanx
Reviewed by
Jubin VScanX News Team
AI Summary

Gujarat Themis Biosyn Limited has initiated a postal ballot to seek shareholder approval for raising ₹1,000 crore through Qualified Institutions Placement. The remote e-voting period runs from June 9 to July 8, 2026, with a record date of June 5, 2026. The Board approved the proposal on June 6, 2026, and the results will be declared by July 10, 2026.

powered bylight_fuzz_icon
42037115

*this image is generated using AI for illustrative purposes only.

Gujarat Themis Biosyn Limited has initiated a postal ballot process to seek shareholder approval for raising funds up to ₹1,000 crore through Qualified Institutions Placement (QIP). The special resolution authorizes the Board to issue equity shares, warrants, or convertible securities to eligible qualified institutional buyers. The company aims to utilize the net proceeds to support its growth strategy, fund strategic projects, and for general corporate purposes, subject to regulatory caps.

The remote e-voting period commenced on June 9, 2026, at 9:00 a.m. IST and will conclude on July 8, 2026, at 5:00 p.m. IST. Members whose names appear on the Register of Members or list of Beneficial Owners as on the cut-off date of June 5, 2026, are eligible to vote. The results of the postal ballot will be declared within two working days after the conclusion of the voting period, latest by July 10, 2026.

Voting Detail Information
Cut-off Date June 5, 2026
Remote e-Voting Start June 9, 2026 (9:00 a.m. IST)
Remote e-Voting End July 8, 2026 (5:00 p.m. IST)
Result Declaration By July 10, 2026
Scrutinizer Mr. Ketan R. Shirwadkar, Proprietor of M/s. KRS & Co.

The Board of Directors, at its meeting held on June 6, 2026, approved the proposal to recommend this special resolution. The issue price will be determined in accordance with Chapter VI of the SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018, and may include a discount of not more than 5% to the floor price. The securities will be allotted in dematerialized form and will be subject to a lock-in period of one year from the date of allotment.

The company has engaged Central Depository Services (India) Limited (CDSL) to facilitate the remote e-voting process. Shareholders can cast their votes through the CDSL or NSDL e-voting systems using their demat account credentials or by logging onto www.evotingindia.com . The notice and explanatory statement are available on the company’s website at www.gtbl.in .

Historical Stock Returns for Gujarat Themis Biosyn

1 Day5 Days1 Month6 Months1 Year5 Years
-1.69%-5.81%+2.24%-3.06%+9.26%+55.51%

What specific strategic projects is Gujarat Themis Biosyn likely to prioritize with the raised funds?

How will the potential equity dilution from the QIP impact existing shareholders in the long term?

What market conditions are driving the company's decision to raise funds through QIP at this time?

like15
dislike

More News on Gujarat Themis Biosyn

1 Year Returns:+9.26%